APR Swiss Independent Pharma Company
APR Applied Pharma Research s.a. (APR) is a Swiss, private independent Pharma company, located in Balerna (Ticino area), the science valley in the south part of Switzerland.
The company is focused on development and commercialization of innovative, science-driven products designed to address unmet needs in niche or rare therapeutic areas on a global basis.
APR combines drug development expertise with proprietary drug delivery technologies to deliver to patients suffering from rare diseases with solutions meaningfully improving their life and empowering caregivers with better ways to manage such rare diseases.
APR has a balanced portfolio of revenue generating branded products marketed in all major markets, combined with a compelling pipeline of innovative products at different stages of development, specifically in the treatment of rare recessive metabolic disorders, rare dermatological and ocular diseases.
Main marketed products are:
- PKU GOLIKE®, an innovative food for special medical purposes (FSMP) consisting of a Phe-free amino acid mixture, powered by the patented Physiomimic™ Technology;
- Nexodyn® AcidOxidizing Solution (AOS), the advanced wound cleanser for acute and chronic wounds care, powered by the patented Tehclo™ Technology Platform;
- An immediate release formulation of Diclofenac K for the treatment of migraine and acute pain powered by the patented Dynamic Buffering Technology;
- Setofilm®, an oral film formulation of Ondansetron indicated for cancer supportive care (in the treatment of CINV, RINV and PONV), powered by the patented Oral Dispersible Film (ODF) technology;
Using various delivery technologies, APR has also developed some Category OTC Healthcare Brands such as Halykoo® and SwitzAGE™.
HalyKoo® is consisting of a complete range of high quality, healthcare solutions specific for baby needs, while SwitzAGE™ is an innovative range of nutraceuticals, 100% Swiss made, specifically created to meet adult people wellbeing needs.
APR provides a wide range of services for the pharmaceutical industry on a contract and fee for service basis: Research and Development services with complete supervision, management and execution of the entire project, development of oral and topical formulations and customized drug delivery technologies.
Some of the APR's products are commercialized directly through its own sale and marketing teams in selected countries of Europe (Italy, Germany, Switzerland and Austria) as well as through a solid global network of commercial partners in all the other countries worldwide.